Mari Aksnes
- Postdoc; PhD
Publications 2024
Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium
Commun Med (Lond), 4 (1), 124
DOI 10.1038/s43856-024-00558-z, PubMed 38937571
Sex-specific associations of kynurenic acid with neopterin in Alzheimer's disease
Alzheimers Res Ther, 16 (1), 167
DOI 10.1186/s13195-024-01531-7, PubMed 39068471
Publications 2023
Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals
Neurobiol Aging, 131, 11-23
DOI 10.1016/j.neurobiolaging.2023.05.012, PubMed 37549446
Sex-specific associations of matrix metalloproteinases in Alzheimer's disease
Biol Sex Differ, 14 (1), 35
DOI 10.1186/s13293-023-00514-x, PubMed 37221606
Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease
Alzheimers Dement, 19 (12), 5573-5582
DOI 10.1002/alz.13162, PubMed 37264981
Publications 2022
Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
J Alzheimers Dis, 86 (3), 1459-1470
DOI 10.3233/JAD-215504, PubMed 35213378
Publications 2021
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front Aging Neurosci, 12, 608628
DOI 10.3389/fnagi.2020.608628, PubMed 33488383
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl Neurodegener, 10 (1), 18
DOI 10.1186/s40035-021-00244-3, PubMed 34099032
Publications 2020
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818